EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.

News | EP Lab

Oral Anticoagulants After Catheter Ablation Helps Reduce Stroke in High-Risk Patients

July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin ...

July 29, 2021

The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right). #HRS21 #HRS2021 #HeartRhythm21

News | EP Lab

Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring

July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG) ...

July 29, 2021

The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device.

News | Cardiac Diagnostics

Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions

July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation ...

July 29, 2021

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...

April 01, 2021

St. Jude Medical Pays $27 Million for Allegedly Selling Defective ICD and CRT-D devices

News | EP Lab

St. Jude Medical Pays $27 Million for Allegedly Selling Defective Heart Devices

July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27 ...

July 28, 2021

Heart Rhythm Society, HRS, 2021 Late-Breaking Clinical Trials in Electrophysiology. #HRS #HRS2021 #HRS21 #Heartrhythm21

Feature | EP Lab

Heart Rhythm Society 2021 Late-Breaking Clinical Trials in Electrophysiology

July 28, 2021 — Here is the complete list of late-breaking clinical trials (LBCT) and links to articles on all of them ...

August 09, 2021

The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.

News | EP Lab

AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment

July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG) technology ...

July 27, 2021

Sponsored Content

Feature | ECG

A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

March 11, 2020

Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.

News | EP Lab

Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas

July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating ...

July 27, 2021

In the past decade there has been a proliferation of clinical-grade wearable monitors and implantable devices such as pacemakers, ICDs, implantable cardiac monitors, and new pacemaker-like devices that can control hypertension. In the near future, these devices will be tied into a body-wide internet of things for specific patients that can transmit patient data to clinicians wirelessly to enable an integrated, more robust form of telecardiology and telemedicine.

Feature | Telecardiology | Victor Wollesen

Next Generation Cardiac Wearables and Implantables Will Integrate Into Wireless Body Area Networks

Cardiovascular diseases are among the leading causes of death for people over 65 years old in North America and Europe ...

July 23, 2021

A live, 3-D intra-cardiac echo (ICE) ultrasound image from inside the atrium of the heart taken during the first cryoablation EP procedure performed using the technology at Northwestern Medicine. The new Philips Healthcare VeriSight Pro ICE catheter offers superior 2-D and 3-D live image guidance for a wide range of procedures in structural heart disease and electrophysiology (EP), allowing interventionalists to navigate procedures.

Feature | Ultrasound Intra-cardiac Echo (ICE)

Northwestern Medicine First in U.S. to Use Live 3D Intracardiac Echo for EP Procedure

July 21, 2021 — Northwestern Medicine Bluhm Cardiovascular Institute recently became the first cardiovascular program in ...

July 21, 2021

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Feature | ECG

Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler. “Plus, my patient compliance has increased. With the Holter, the leads sometimes come off. The patient may think the device isn’t working, so they take it off and we have to restart the process.”

February 19, 2020

ICE image showing the inside of the heart. Mayo Clinic recently became the first to use the next-generation Philips 4-D intracardiac echo imaging catheter. ICE is seeing increased use in structural heart procedures.

News | Ultrasound Intra-cardiac Echo (ICE)

Mayo Clinic First to Use Next Generation 4D ICE System to Guide Structural Heart Procedures

July 16, 2021 — Mayo Clinic recently became the first to use a next-generation 4-D intracardiac echo (ICE) imaging ...

July 16, 2021

Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the Reveal Linq Insertable Cardiac Monitor (ICM) to detect abnormal heartbeats, otherwise known as atrial fibrillation (AF), in both large and small vessel stroke patients compared to standard of care.

News | Implantable Cardiac Monitor (ICM)

Medtronic Insertable Cardiac Monitor Detects Significantly Higher Rates of Atrial Fibrillation in Large and Small Vessel Stroke Patients Compared to Standard of Care

June 13, 2021 — Medtronic announced clinical trial results from the STROKE AF trial demonstrating the superiority of the ...

July 14, 2021

ast End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company's SafeCross Transseptal Radiofrequency (RF) Puncture and Steerable Balloon Introducer System. The 3-in-1 system, which includes a steerable introducer sheath with an ultra-visible positioning balloon and radiofrequency (RF) puncture dilator, aims to provide a predictable and safe solution for electrophysiology (EP) and structural heart interventions requiring left atrial access.

News | Cath Lab

FDA Clears SafeCross Transseptal RF Puncture and Steerable Balloon Introducer System

July 13, 2021 — East End Medical announced it received U.S. Food and Drug Administration (FDA) clearance for the company ...

July 14, 2021

Sponsored Content

Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.

Feature | Sudden Cardiac Arrest

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease

Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent worldwide. Most professional athletes in the United States are required to take part in comprehensive cardiovascular screening programs to identify often-asymptomatic congenital or inherited heart disorders, and other cardiac risk factors. There remains a debate however, whether to mandate ECGs as part of pre-participation screening programs for student athletes at the collegiate and high school levels or even at younger ages.

October 16, 2018